UY36983A - REPLACED PIRAZOLOPIRIDINAMINS - Google Patents

REPLACED PIRAZOLOPIRIDINAMINS

Info

Publication number
UY36983A
UY36983A UY0001036983A UY36983A UY36983A UY 36983 A UY36983 A UY 36983A UY 0001036983 A UY0001036983 A UY 0001036983A UY 36983 A UY36983 A UY 36983A UY 36983 A UY36983 A UY 36983A
Authority
UY
Uruguay
Prior art keywords
compounds
preparing
pirazolopiridinamins
replaced
disorder
Prior art date
Application number
UY0001036983A
Other languages
Spanish (es)
Inventor
Georg Kettschau Dr
Nicole Schmidt Dra
Anja Giese Dra
Stephan Menz Dr
Heike Schäcke Dra
Alexandra Rausch Dra
Peter Hauff Dr
Ina Gröticke Dra
Ulrich Klar Dr
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY36983A publication Critical patent/UY36983A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se relaciona con compuestos de pirazolopiridinamina sustituida de fórmula general (I) como se describe y se define en la presente, con métodos para preparar dichos compuestos, con compuestos intermediarios útiles para preparar dichos compuestos, con composiciones farmacéuticas y combinaciones que comprenden dichos compuestos y con el uso de dichos compuestos para la fabricación de una composición farmacéutica para el tratamiento o profilaxis de una enfermedad, en particular de un trastorno hiperproliferativo, trastorno de angiogénesis, enfermedades inflamatorias o enfermedades asociadas con dolor inflamatorio, como agente único o en combinación con otros ingrediente activos.The present invention relates to substituted pyrazolopyridinamine compounds of the general formula (I) as described and defined herein, with methods for preparing said compounds, with intermediates useful for preparing said compounds, with pharmaceutical compositions and combinations comprising said compounds and with the use of said compounds for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disorder, angiogenesis disorder, inflammatory diseases or diseases associated with inflammatory pain, as a single agent or in combination with other active ingredients.

UY0001036983A 2015-11-12 2016-11-11 REPLACED PIRAZOLOPIRIDINAMINS UY36983A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15194337 2015-11-12

Publications (1)

Publication Number Publication Date
UY36983A true UY36983A (en) 2017-06-30

Family

ID=54540977

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036983A UY36983A (en) 2015-11-12 2016-11-11 REPLACED PIRAZOLOPIRIDINAMINS

Country Status (3)

Country Link
AR (1) AR106664A1 (en)
UY (1) UY36983A (en)
WO (1) WO2017081003A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104507950B (en) * 2012-05-21 2017-03-22 拜耳医药股份有限公司 Thienopyrimidines
EA201791363A1 (en) * 2014-12-19 2018-01-31 Байер Фарма Акциенгезельшафт PYRAZOLOPIRIDINAMINES AS MKNK1 AND MKNK2 INHIBITORS

Also Published As

Publication number Publication date
WO2017081003A1 (en) 2017-05-18
AR106664A1 (en) 2018-02-07

Similar Documents

Publication Publication Date Title
ECSP19030002A (en) 1,2,4-TRIAZOLONES 2,4,5-TRISUSTITUIDED
ECSP17007538A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES
UY35040A (en) PIRROLOPIRIMIDINILAMINO-BENZOTIAZOLONAS REPLACED
CO2020001244A2 (en) Quinoline derivatives to treat helminth infections
NI201700078A (en) Pyrazolpyridinamines
UY33598A (en) IMIDAZOPIRIDAZINAS REPLACED
DOP2014000051A (en) IMIDAZOPIRIDAZINAS REPLACED WITH AMINO
UY37577A (en) DIHYDROIMIDAZOPIRIDINDIONAS REPLACED
NI201600006A (en) PYRAZOLO-PYRIDINAMINES SUBSTITUTED
DOP2016000253A (en) NEW COMPOUNDS
ECSP20008441A (en) DIHYDROOXADIAZINONES
UY35848A (en) TIENOPIRIMIDINS
CR20150455A (en) IMIDAZOPIRIDAZINAS REPLACED
UY37444A (en) SUBSTITUTED DERIVATIVES OF 6- (1H-PIRAZOL-1-IL) PIRIMIDIN-4-AMINA AND ITS USE
UY36983A (en) REPLACED PIRAZOLOPIRIDINAMINS
UY37032A (en) HETEROARILBENZIMIDAZOL COMPOUNDS
UY34630A (en) IMIDAZOPIRIDAZINAS REPLACED WITH AMINO

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20221212